Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/1999
03/11/1999CA2294110A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity
03/11/1999CA2294074A1 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/10/1999EP0900848A2 MecB polynucleotides and polypeptides from the Clpc ATPase family of Stapyloccoccus aureus
03/10/1999EP0900847A2 Phosphoribosyl transferase from Staphylococcus aureus
03/10/1999EP0900845A2 Signal recognition particle polypeptides and polynucleotides
03/10/1999EP0900844A2 Membrane protein of Staphylococcus aureus
03/10/1999EP0900799A1 Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones
03/10/1999EP0900789A2 Substituted quinolone derivatives and pharmaceuticals containing the same
03/10/1999EP0900562A1 Lavage solution for intestinal tract
03/10/1999EP0900272A2 Tumor necrosis factor alpha convertase
03/10/1999EP0900219A1 Heterocyclic compounds
03/10/1999EP0900218A1 Heterocyclic compounds
03/10/1999EP0900217A1 Heterocyclic compounds
03/10/1999EP0900211A1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors
03/10/1999EP0900204A1 Heterocyclic compounds
03/10/1999EP0900202A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs
03/10/1999EP0900083A1 Novel substituted imidazole compounds
03/10/1999EP0900080A1 Novel indole and benzothiazole derivatives
03/10/1999EP0722438B1 Hydroxamic acid derivatives as inhibitors of cytokine production
03/10/1999CN1210517A Hydroxamic acid derivatives for use with treatment of diseases related to connective tissue degradation
03/10/1999CN1210466A Colonic delivery of nicotine to treat inflammatory bowel disease
03/10/1999CN1210015A Quick action powder for stomachache
03/10/1999CN1210013A Products and preparation of Qingqiutesu
03/10/1999CN1210006A Powder for disinfection
03/10/1999CN1210002A Application of tea pigments in preparation of medicine for fatty liver
03/09/1999US5880152 Inflammatory bowel disease
03/09/1999US5880151 Treating or preventing disease characterized by high levels of low density lipoprotein particles or cholesterol in blood
03/09/1999US5880141 Controlling, modulating and inhibiting tyrosine kinase signal transduction
03/09/1999US5880119 Angiotensin converting enzyme inhibitors; analgesics, hypotensive agents, diuretics; treating congestive heart failure, irritable bowel syndrome
03/09/1999US5879688 Treatment of skin disorders, wrinkling, aging
03/08/1999CA2242476A1 Novel compositions containing cyclosporin
03/04/1999WO1999010360A1 Oligosaccharide derivatives and process for producing the same
03/04/1999WO1999010339A1 2-aminopyridines containing fused ring substituents as nos inhibitors
03/04/1999WO1999010325A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
03/04/1999WO1999010313A1 N-aroylphenylalanine derivatives
03/04/1999WO1999010312A1 N-alkanoylphenylalanine derivatives
03/04/1999WO1999010292A2 Robustaflavone, intermediates and analogues and method for preparation thereof
03/04/1999WO1999010003A1 Androgen activity antagonists as therapies for anorexia, anorexia nervosa, and disorders characterized by a pathologically underweight condition
03/04/1999WO1999010000A1 Combined preparations for treating upper gastrointestinal tract distress
03/04/1999WO1999009983A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
03/04/1999CA2550132A1 Rapidly disintegrating methylcellulose tablets
03/04/1999CA2550041A1 Rapidly disintegrating methylcellulose tablets
03/04/1999CA2543223A1 Rapidly disintegrating methylcellulose tablets
03/04/1999CA2301893A1 Oligosaccharide derivatives and process for producing the same
03/04/1999CA2301780A1 Androgen activity antagonists as therapies for anorexia, anorexia nervosa, and disorders characterized by a pathologically underweight condition
03/04/1999CA2301549A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
03/04/1999CA2300121A1 N-alkanoylphenylalanine derivatives
03/04/1999CA2242260A1 Spo0j1
03/04/1999CA2242258A1 Novel compounds
03/03/1999EP0899336A2 Streptococcus pneumoniae spoIIIE protein
03/03/1999EP0899335A2 MurB gene from Staphylococcus aureus
03/03/1999EP0899333A2 Ribonucleotide reductase gene nrdD from Staphylococcus aureus
03/03/1999EP0899332A2 The G-protein coupled receptor HFIAO41
03/03/1999EP0899268A2 Process for the preparation of omeprazole and intermediate compounds
03/03/1999EP0899264A1 7-Phenyl-1,4-diazepane derivatives as neurokinine receptor antagonists
03/03/1999EP0899261A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists
03/03/1999EP0898562A1 Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation
03/03/1999EP0745080B1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
03/03/1999EP0737194B1 Diazabicyclic neurokinin antagonists
03/03/1999EP0675893B1 Anticonvulsant sorbopyranose sulfamates
03/03/1999EP0674641B1 Pyrrolopyrimidines as crf antagonists
03/03/1999CN1209339A Medicine for treating colonitis
03/03/1999CN1209314A Oral-cavity cleaning liquor for preventing and curing disease of oral cavity and preparation method thereof
03/03/1999CA2242313A1 Signal recognition particle polypeptides and polynucleotides
03/02/1999US5877321 Neurokinin receptor
03/02/1999US5877316 Treatment of pain, inflammation, migraine and emesis.
03/02/1999US5877189 Pure isomer
03/02/1999US5877188 Psychological and behavioral disorders, antiemetics
03/02/1999US5877016 Human trk receptors and neurotrophic factor inhibitors
03/02/1999US5876943 Antigenic polypeptide produced by genetic engineering for use in diagnosis of and vaccines to peptic ulcers and stomach cancer
03/02/1999CA2242315A1 Mecb
02/1999
02/28/1999CA2246118A1 Substituted quinolone derivatives and pharmaceuticals containing the same
02/28/1999CA2241427A1 Novel pyrr homolog
02/26/1999CA2241431A1 Novel spoiiie
02/25/1999WO1999009061A1 Secreted proteins
02/25/1999WO1999009029A1 PYRROLO[3,2-c]QUINOLINE DERIVATIVES CONTAINING HALOALKOXY GROUP AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
02/25/1999WO1999009025A2 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor
02/25/1999WO1999009015A1 2-{3-[4-(2-t-butyl-6- trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto} pyrimidin-4-ol-fumarate
02/25/1999WO1999008691A2 Use of locally delivered metal ions for treatment of periodontal disease
02/25/1999WO1999008678A1 Heterocyclic vinylethers against neurological disorders
02/25/1999WO1999008671A1 Gaba analogs to prevent and treat gastrointestinal damage
02/25/1999WO1999008670A1 Gaba analogs to prevent and treat gastrointestinal damage
02/25/1999WO1999008656A1 Antacid composition
02/25/1999WO1999008500A2 New crystalline form of omeprazole
02/25/1999WO1998053101A3 Methods and composition to identify swine genetically resistant to f18 e. coli associated diseases
02/25/1999WO1998053050A3 Short peptides which selectively modulate the activity of serine/threonine kinases
02/25/1999DE19837386A1 New CCR-3 antagonist piperazine derivatives and analogues
02/25/1999CA2363810A1 New form of omeprazole
02/25/1999CA2301297A1 2-{3-[4-(2-t-butyl-6- trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto} pyrimidin-4-ol-fumarate
02/25/1999CA2301292A1 Antacid composition
02/25/1999CA2301065A1 Use of locally delivered metal ions for treatment of periodontal disease
02/25/1999CA2241430A1 Novel murb
02/25/1999CA2241392A1 Pigr-2, a member of immunoglobulin gene superfamily
02/24/1999EP0897981A1 Pigr-1, a member of immunoglobulin gene superfamily
02/24/1999EP0897979A2 Human sdr2 cdna clone
02/24/1999EP0897386A1 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
02/24/1999EP0897303A1 Inhibitors of farnesyl-protein transferase
02/24/1999CN1209129A Antagonists of gonadotropin releasing hormone
02/24/1999CN1209125A Piperazine derivatives as tachykinin antagonists
02/24/1999CN1209117A N-acylaminoalkylhydrzinecarboximidamides
1 ... 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 ... 1258